title: Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium.
authors.forename: Beamon
authors.initials: B
authors.lastname: Agarwal
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Campen
authors.forename: Meghan M
authors.initials: MM
authors.lastname: Channell
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Wherry
authors.forename: Behzad
authors.initials: B
authors.lastname: Varamini
authors.forename: James G
authors.initials: JG
authors.lastname: Davis
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Baur
authors.forename: James M
authors.initials: JM
authors.lastname: Smoliga
mesh_terms: D050197:Atherosclerosis / Q000097:blood / Q000235:genetics / Q000517:prevention & control*; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008297:Male; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D013267:Stilbenes; D000077185:Resveratrol